NBA: Report: Spurs C Victor Wembanyama cleared to return

Date:

Share post:


San Antonio Spurs center Victor Wembanyama has recovered from the blood clot issue that prematurely ended his 2024-25 season, the French newspaper L’Equipe reported Monday.

“I’m officially cleared to return,” Wembanyama told the publication. “It just happened — I got the green light from the Spurs’ medical staff. … I’ll finally be able to play a bit of basketball again.”

Wembanyama underwent surgery in March after being diagnosed with deep vein thrombosis in his right shoulder.

ESPN reported in May that Wembanyama was expected to be back on the court by the start of training camp and a full-go in time for the regular season.

The 21-year-old Frenchman averaged 24.3 points, 11.0 rebounds, 3.7 assists and an NBA-leading 3.8 blocked shots in 46 starts in 2024-25.

Named the unanimous NBA Rookie of the Year in 2023-24, the 7-foot-3 Wembanyama competed in his first All-Star Game in 2024-25.

The Spurs selected Wembanyama first overall in the 2023 NBA Draft. In parts of two seasons, he is averaging 22.5 points, 10.8 rebounds, 3.8 assists, 1.2 steals and 3.7 blocked shots in 117 games (all starts). He also has made 270 3-pointers.

–Field Level Media

spot_img

Related articles

NCAAB: Omaha forward Deng Mayar, 22, dies in drowning incident

Omaha men's basketball player Deng Mayar, a graduate transfer from North Dakota, died on Saturday in a drowning...

NBA: Lakers G Luka Doncic cleared to play for Slovenia after injury scare

Two days after Los Angeles Lakers star Luka Doncic left a game for his native Slovenia following a...

NBA: Report: Bobby Webster absorbs Raptors’ team president duties

The Toronto Raptors are adding president of basketball operations duties onto the plate of general manager Bobby Webster,...

WNBA: Fever G Sophie Cunningham (knee) exits vs. Sun with injury

The already-shorthanded Indiana Fever were dealt another injury blow in the second quarter of their Sunday game against...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.